Q1 FY27 snapshot
Announcement Date27-Jul-26
Revenue (Top Line)₹183 Cr
Net Profit (Bottom Line)₹31 Cr
Earnings Per Share (EPS)₹6.67
Expenses₹152 Cr
Net profit margin (calculated)16.9%
Senores Pharmaceuticals Ltd. (SENORES) Quarterly Results: Q1 FY27
Quick answer: Senores Pharmaceuticals Ltd. (NSE: SENORES) reported Q1 FY27 revenue of ₹183 Cr and net profit of ₹31 Cr, with earnings per share (EPS) of ₹6.67, announced on 27-Jul-26.
That works out to a net profit margin of about 16.9% for the quarter.
Note: figures are pulled automatically from company filings and may lag or contain gaps. Verify on NSE or BSE. Not investment advice.
How to read Senores Pharmaceuticals Ltd.'s Q1 FY27 results
Revenue of ₹183 Cr is what Senores Pharmaceuticals Ltd. earned before costs. Net profit of ₹31 Cr is what remained for shareholders after expenses, interest and tax. Dividing one by the other gives a net margin of about 16.9%, a quick gauge of how much of each rupee of sales is kept as profit.
New to results? Read our guide on how to read quarterly results, see the full results list or the dividend calendar.
FAQs
Senores Pharmaceuticals Ltd. results FAQs
What were Senores Pharmaceuticals Ltd.'s Q1 FY27 results?
Senores Pharmaceuticals Ltd. (NSE: SENORES) reported Q1 FY27 revenue of ₹183 Cr and net profit of ₹31 Cr, with earnings per share (EPS) of ₹6.67, announced on 27-Jul-26.
What is Senores Pharmaceuticals Ltd.'s EPS for Q1 FY27?
Senores Pharmaceuticals Ltd.'s earnings per share for Q1 FY27 was ₹6.67. EPS is net profit divided by the number of outstanding shares.
When did Senores Pharmaceuticals Ltd. announce its Q1 FY27 results?
Senores Pharmaceuticals Ltd. announced its Q1 FY27 results on 27-Jul-26.
What is Senores Pharmaceuticals Ltd.'s net profit margin?
On the reported figures, Senores Pharmaceuticals Ltd.'s Q1 FY27 net profit margin is about 16.9% (net profit ÷ revenue).